Medications for Polyradiculoneuropathy Chronic Inflammatory Demyelinating

6 results

  • gammagard liquid

    (Immune Globulin Infusion (Human))
    Takeda Pharmaceuticals America, Inc.
    GAMMAGARD LIQUID is indicated for replacement therapy in primary immunodeficiency (PI) in patients aged two or older, and as maintenance therapy to improve muscle strength in adult patients with multifocal motor neuropathy (MMN) and to reduce disability in chronic inflammatory demyelinating polyneuropathy (CIDP).

  • gammaked

    (Immune Globulin (Human))
    KEDRION BIOPHARMA, INC.
    GAMMAKED is indicated for the treatment of primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve disability and prevent relapse.

  • gamunex-c

    (Immune Globulin (Human))
    GRIFOLS USA, LLC
    GAMUNEX-C is indicated for treating primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to enhance neuromuscular function and prevent relapses.

  • hizentra

    (HUMAN IMMUNOGLOBULIN G)
    CSL Behring AG
    HIZENTRA is indicated for the treatment of primary immunodeficiency in patients aged 2 and older, including various humoral immune defects. It is also used as maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability.

  • hyqvia

    (Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase)
    Takeda Pharmaceuticals America, Inc.
    HYQVIA is indicated for treating primary immunodeficiency (PI) in adults and children over two, including conditions like common variable immunodeficiency and Wiskott-Aldrich syndrome. It is also used as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to prevent relapse of neuromuscular symptoms.

  • vyvgart hytrulo

    (efgartigimod alfa and hyaluronidase (human recombinant))
    argenx US
    VYVGART HYTRULO is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-AChR antibody positive and for chronic inflammatory demyelinating polyneuropathy (CIDP).